[Characteristics of RNA metabolism in the presence of inhibitors of energy metabolism].
D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism; D003486:Cyanides / Q000494:pharmacology; D003864:Depression, Chemical; D004140:Dinitrophenols / Q000494:pharmacology; D004734:Energy Metabolism / Q000187:drug effects*; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D007461:Iodoacetates / Q000494:pharmacology; D007700:Kinetics; D009374:Neoplasms, Experimental / Q000378:metabolism; D009840:Oligomycins / Q000494:pharmacology; D010051:Ovarian Neoplasms / Q000378:metabolism; D012334:RNA, Neoplasm / Q000096:biosynthesis / Q000378:metabolism*; D012402:Rotenone / Q000494:pharmacology
D001386:Azides; D002250:Carbon Radioisotopes; D003486:Cyanides; D004140:Dinitrophenols; D007461:Iodoacetates; D009840:Oligomycins; D012334:RNA, Neoplasm; D012402:Rotenone; D000968:Antimycin A; D005459:Fluorides
Osobennosti metabolizma RNK v prisutstvii ingibitorov énergeticheskogo obmena